References
- TozerGMKanthouCParkinsCSHillSAThe biology of the combretastatins as tumour vascular targeting agentsInt J Exp Pathol2002831213812059907
- WestCMPricePCombretastatin A4 phosphateAnticancer Drugs200415317918715014350
- GriggsJHeskethRSmithGACombretastatin-A4 disrupts neovascular development in non-neoplastic tissueBr J Cancer200184683283511259100
- NabhaSMWallNRMohammadRMPettitGRAl-KatibAMEffects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell linesAnticancer Drugs200011538539210912955
- El-ZayatADegenDDrabekSClarkGMPettitGRVon HoffDDIn vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub)Anticancer Drugs19934119258457709
- LawrenceNJRennisonDWooMMcGownATHadfieldJAAntimitotic and cell growth inhibitory properties of combretastatin A-4-like ethersBioorg Med Chem Lett2001111515411140732
- DorrRTDvorakovaKSneadKAlbertsDSSalmonSEPettitGRAntitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorInvest New Drugs19961421311378913833
- RustinGJGalbraithSMAndersonHPhase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic resultsInt J Clin Oncol2003211528152822
- YoungSLChaplinDJCombretastatin A4 phosphate: background and current clinical statusExpert Opin Investig Drugs200413911711182
- ZhangYFWangJCBianDYZhangXZhangQTargeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studiesEur J Pharm Biopharm201074346747320064608
- NallamothuRWoodGCPattilloCBA tumor vasculature targeted liposome delivery system for combretastatin A4: Design, characterization, and in vitro evaluationAAPS Pharm Sci Tech200672E110
- WangYYangTWangXWangJZhangXZhangQTargeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitroPharm Res20102791861186820559700
- WangYGYangTYWangXMaterializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle systemJ Control Release2011149329930621044651
- WangZChuiWKHoPCNanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapyPharm Res201128358559621057857
- FalcianiCBrunettiJPagliucaCDesign and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agentsChem Med Chem20105456757420222099
- SenguptaSEavaroneDCapilaITemporal targeting of tumour cells and neovasculature with a nanoscale delivery systemNature2005436705056857216049491
- PattilloCBVenegasBDonelsonFJRadiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumorsPharm Res20092651093110019172383
- MaLLiuYLMaZZTargeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4J Ocul Pharmacol Ther200925319520019456253
- WangZHoPCA nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activitiesBiomaterials201031277115712320576288
- WangZHoPCSelf-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activitiesSmall20106222576258320976704
- TomaliaDAFrechetJMDendrimers and Other Dendritic PolymersNew York, NYJohn Wiley and Sons Ltd2001
- TomaliaDANaylorAMGoddardWAIIIStarburst dendrimers: control of size, shape, surface chemistry, topology and flexibility in the conversion of atoms to macroscopic materialsAngew Chem Int Ed199029138175
- PatriAKMajorosIJBakerJRDendritic polymer macromolecular carriers for drug deliveryCurr Opin Chem Biol20026446647112133722
- EsfandRTomaliaDAPoly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applicationsDrug Discov Today20016842743611301287
- ShiXLeeIChenXInfluence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimersSoft Matter20106112539254520852741
- WangYCaoXGuoRTargeted delivery of doxorubicin into cancer cells using a folic acid-dendrimer conjugatePolym Chem2011217541760
- WangYGuoRCaoXShenMShiXEncapsulation of 2-methoxyestradiol within multifunctional poly (amidoamine) dendrimers for targeted cancer therapyBiomaterials2011323322332921315444
- AgarwalAGuptaUAsthanaAJainNKDextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agentBiomaterials2009303588359619344947
- ChandraSDietrichSLangHBahadurDDendrimer-Doxorubicin conjugate for enhanced therapeutic effects for cancerJ Mater Chem20112157295737
- GuillaudeuSJFoxMEHaidarYMDyEESzokaFCFréchetJMPEGylated dendrimers with core functionality for biological applicationsBioconjugate Chem2008192461469
- MajorosIJThomasTPMehtaCBBakerJRJrPoly (amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapyJ Med Chem200548195892589916161993
- MajorosIJMycAThomasTMehtaCBBakerJRJrPAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionalityBiomacromolecules20067257257916471932
- BakerJRJrQuintanaAPiehlerLBanazak-HollMTomaliaDRaczkaEThe synthesis and testing of anti-cancer therapeutic nanodevicesBiomed Microdevices2001316169
- Kukowska-LatalloJFCandidoKACaoZYNanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res200565125317532415958579
- ThomasTPMajorosIJKotlyarATargeting and inhibition of cell growth by an engineered dendritic nanodeviceJ Med Chem200548113729373515916424
- ShiXWangSHLeeIShenMBakerJRJrComparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cellsBiopolymers2009911193694219603491
- ShiXWangSHSwansonSDDendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumorsAdv Mater200820916711678
- PapadopoulosSJürgensKDGrosGProtein diffusion in living skeletal muscle fibers: dependence on protein size, fiber type, and contractionBiophys J2000792084209411023912
- PeerDKarpJMHongSFarokHzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
- ShiXWangSMeshinchiSDendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imagingSmall200731245125217523182
- WangSHShiXYVan AntwerpMDendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cellsAdv Funct Mater2007171630433050
- HongSLeroueilPRMajorosIJOrrBGBakerJRJrBanaszak HollMMThe binding avidity of a nanoparticle-based multivalent targeted drug delivery platformChem Biol20071410711517254956
- CakaraDKleimannJBorkovecMMicroscopic protonation equilibria of poly (amidoamine) dendrimers from macroscopic titrationsMacromolecules2003361142014207
- GarinchesaPCampbellISaigoPELewisJLOldLJRettigWJTrophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding proteinAm J Pathol199314225575678434649